[for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose ("Act") or otherwise subject to]
[Home Inns Reports First Quarter 2011 Financial Results Revenuesreased 11% Year over Year to $757million Shanghai, May9, 2011 First Quarter 2011 Financial Highlights Total revenues for the first quarterreased 10.8% year over year to RMB 756.6million (US$115.5million). Netome attributable to Home Inns shareholders for the quarter was RMB 32.5million (US$5.0million). Netome was reduced by share-basedmpensation]
[Hanwha SolarOne to Announce First Quarter 2011 Financial Results on May 24, 2011 SHANGHAI, China (May 10, 2011) Hanwha SolarOne Co., Ltd. (“Hanwha SolarOne” or the “Company”) (NASDAQ: HSOL), a vertically integrated manufacturer of silicon ingots, wafers and photovoltaic (“PV”) cells and modules in China, Conference Call Dr. Peter Xie, President and CEO, Mr. Gareth Kung, Chief Financial Officer, and] [99.1 Press Release Dated May 10, 2011. HANWHA SOLARONE CO., LTD]
[JINPAN INTERNATIONAL LIMITED]
[Company Contact China Biologic Products Corrects two Administrative Errors in its May 9, 2011 Earnings Release Tai'an, Shandong Province, PRC, May 10, 2011 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today corrected two administrative errors in its earnings release issued on] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 10, 2011 (May 9, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former]
[Home Inns Reports First Quarter 2011 Financial Results Revenuesreased 11% Year over Year to $757million Shanghai, May9, 2011 First Quarter 2011 Financial Highlights Total revenues for the first quarterreased 10.8% year over year to RMB 756.6million (US$115.5million). Netome attributable to Home Inns shareholders for the quarter was RMB 32.5million (US$5.0million). Netome was reduced by share-basedmpensation]
[FORM 10-Q þ For the quarterly period ended: March 31, 2011 ¨ For the transition period from: _____________ to _____________ KINGOLD JEWELRY, INC. Delaware 001-15819 13-3883101 (State or Other Jurisdiction (Commission (I.R.S. Employer of Incorporation) Identification No.) 15 Huangpu Science and Technology Park Jiang’an District Wuhan, Hubei Province, PRC 430023 (011) 86 27 65694977 (Former name, former address and former] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Zhihong Jia, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Kingold Jewelry, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION OF CHIEF FINANCIAL OFFICER UNDER SECTION 302 OF THE SARBANES-OXLEY ACT I, Bin Liu, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Kingold Jewelry, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Zhihong Jia Chairman, Chief Executive Officer and EX-32.1 4 v221274_ex32-1.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) Bin Liu Chief Financial Officer and Principal Accounting Officer EX-32.2 5 v221274_ex32-2.htm]
[JINPAN INTERNATIONAL LIMITED]
[Company Contact China Biologic Products Corrects two Administrative Errors in its May 9, 2011 Earnings Release Tai'an, Shandong Province, PRC, May 10, 2011 China Biologic Products, Inc. (NASDAQ: CBPO) (China Biologic or the Company), one of the leading plasma-based biopharmaceutical companies in the Peoples Republic of China (PRC), today corrected two administrative errors in its earnings release issued on] [FORM 8-K CURRENT REPORT Date of Report (Date of Earliest event Reported): May 10, 2011 (May 9, 2011) CHINA BIOLOGIC PRODUCTS, INC. Delaware 001-34566 75-2308816 (State or other jurisdiction of (Commission File No.) (IRS Employer ID No.) incorporation or organization) No. 14 East Hushan Road, Tai'an City, Shandong, 271000 People's Republic of China 86-538 -620-2306 ____________________________________________________________ (Former name or former]
[FORM 10-Q (Mark One) x March 31, 2011 For the quarterly period ended o For the transition period from ____________ to ____________ CHINA PHARMAS, Delaware 73-1564807 (State or other jurisdiction of (IRS Employerorporation or organization) Identification No.) Second Floor, No. 17, Jinpan Road Haikou, Hainan Province, China570216 +86 898-6681-1730 (China)] [CERTIFICATION I, Zhilin Li certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [CERTIFICATION I, Frank Waung, certify that: 1. I have reviewed this report on Form 10-Q of China Pharmas,; 2. Based on my knowledge, this report does notntain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 10, 2011 -------------------------------- President and Chief Executive Officer cphi10qex321033111.htm 4 EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THERBANES-OXLEY ACT OF 2002 (2) The informationntained in the Report fairly presents, inl material respects, the financialndition and results of operations of thempany.ted:May 10, 2011 --------------------- (principal financial officer and principal accounting officer) cphi10qex322033111.htm 5 EX-32.2]
